NO20053715L - 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk - Google Patents

10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk

Info

Publication number
NO20053715L
NO20053715L NO20053715A NO20053715A NO20053715L NO 20053715 L NO20053715 L NO 20053715L NO 20053715 A NO20053715 A NO 20053715A NO 20053715 A NO20053715 A NO 20053715A NO 20053715 L NO20053715 L NO 20053715L
Authority
NO
Norway
Prior art keywords
dialkylprostanoic
agents
acid derivatives
indicates
glaucoma
Prior art date
Application number
NO20053715A
Other languages
English (en)
Other versions
NO20053715D0 (no
NO334659B1 (no
Inventor
Yariv Donde
Jeremiah H Nguyen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/365,369 external-priority patent/US6875787B2/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO20053715D0 publication Critical patent/NO20053715D0/no
Publication of NO20053715L publication Critical patent/NO20053715L/no
Publication of NO334659B1 publication Critical patent/NO334659B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for behandling av okulær hypertensjon eller glaukom, som omfatter å administrere til et dyr som har okulær hypertensjon eller glaukom en terapeutisk effektiv mengde av en forbindelse representert ved den generelle formel (I); hvor den stiplede linjen indikerer nærvær eller fravær av en binding, den skraverte kilen indikerer a- (ned) konfigurasjonen, og det fylte triangelet indikerer ß- (opp) konfigurasjonen; B er en enkel, dobbel eller trippel kovalent binding; n er 0-6; X er CH2, S eller O; Y er et hvilket som heist farmasøytisk akseptabelt salt av CO2H, eller CO2R, CONR2, CONHCH2CH2OH, CON(CH2CH2OH)2, CH2OR, P(O)(OR)2, CONRSO2R, SONR2, eller formel (la) R er H, C1-6-alkyl eller C2-6-alkenyl; R2 og R3 er lineært C1-6-alkyl som kan være like eller forskjellige, og kan være bundet til hverandre slik at de danner en ring som innlemmer karbonatomet som de i fellesskap er festet til.
NO20053715A 2003-02-11 2005-08-01 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk NO334659B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/365,369 US6875787B2 (en) 2003-02-11 2003-02-11 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US10/772,720 US20040235958A1 (en) 2003-02-11 2004-02-04 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
PCT/US2004/003433 WO2004071428A2 (en) 2003-02-11 2004-02-06 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Publications (3)

Publication Number Publication Date
NO20053715D0 NO20053715D0 (no) 2005-08-01
NO20053715L true NO20053715L (no) 2005-10-27
NO334659B1 NO334659B1 (no) 2014-05-12

Family

ID=32871611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053715A NO334659B1 (no) 2003-02-11 2005-08-01 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk

Country Status (12)

Country Link
EP (1) EP1608309B1 (no)
JP (1) JP5319065B2 (no)
KR (1) KR101077461B1 (no)
AU (1) AU2004211936B2 (no)
BR (1) BRPI0407400A (no)
CA (1) CA2515631C (no)
MX (1) MXPA05008431A (no)
NO (1) NO334659B1 (no)
NZ (1) NZ541352A (no)
PL (1) PL209130B1 (no)
RU (1) RU2336081C2 (no)
WO (1) WO2004071428A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
JP2008518013A (ja) * 2004-10-26 2008-05-29 アラーガン、インコーポレイテッド プロスタグランジンep4アゴニストによる処置方法およびデリバリー方法
AU2012200514B2 (en) * 2005-03-17 2014-03-06 Allergan, Inc. Treatment of inflammatory bowel disease
WO2008041054A1 (en) * 2006-10-02 2008-04-10 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
CN105566192B (zh) * 2006-10-02 2019-01-22 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7732443B2 (en) * 2008-03-18 2010-06-08 Yariv Donde Therapeutic substituted cyclopentanes
AU2009244541B2 (en) * 2008-05-09 2014-01-09 Allergan, Inc. Therapeutic compounds
JP2013508282A (ja) 2009-10-14 2013-03-07 ジェンムス ファーマ インコーポレイティド ウイルス感染のための併用療法処置
US20120136011A1 (en) * 2010-07-30 2012-05-31 Allergan, Inc. Compounds and methods for skin repair
US20120046332A1 (en) * 2010-08-17 2012-02-23 Allergan, Inc. Compositions and methods for treating corneal haze
EP3884935B1 (en) 2013-08-09 2023-06-14 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117014A (en) * 1976-01-09 1978-09-26 Abbott Laboratories Prostaglandin derivatives
JPS59101458A (ja) * 1982-12-01 1984-06-12 Nippon Iyakuhin Kogyo Kk 新規なチアプロスタグランジン誘導体及びその製法
JPS632972A (ja) * 1986-06-20 1988-01-07 Nippon Iyakuhin Kogyo Kk 新規プロスタグランジンe↓1誘導体及びその製法
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6410591B1 (en) * 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
CA2450466C (en) * 2001-06-14 2011-07-05 Allergan, Inc. 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
MXPA05008431A (es) 2005-10-19
NO20053715D0 (no) 2005-08-01
CA2515631C (en) 2013-08-20
JP5319065B2 (ja) 2013-10-16
KR101077461B1 (ko) 2011-10-26
WO2004071428A2 (en) 2004-08-26
AU2004211936B2 (en) 2008-09-11
RU2005129072A (ru) 2006-02-27
EP1608309B1 (en) 2012-07-11
KR20050101202A (ko) 2005-10-20
AU2004211936A1 (en) 2004-08-26
PL378421A1 (pl) 2006-04-03
NZ541352A (en) 2007-12-21
JP2006517587A (ja) 2006-07-27
EP1608309A2 (en) 2005-12-28
NO334659B1 (no) 2014-05-12
PL209130B1 (pl) 2011-07-29
RU2336081C2 (ru) 2008-10-20
CA2515631A1 (en) 2004-08-26
BRPI0407400A (pt) 2006-02-21
WO2004071428A3 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
NO20053715L (no) 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk
ES2399314T3 (es) Gamma lactamas sustituidas como agentes terapeúticos
CY1113138T1 (el) Παραγωγα 10,10-διαλκυλ προστανοϊκου οξεος ως παραγοντες για μειωση ενδο-οφθαλμικης πιεσης
EA200500814A1 (ru) Производные пирролопиримидина
AR044543A1 (es) Derivados de pirazolo-quinazolina, un procedimiento para su preparacion y su uso como inhibidor de quinasa
SG159380A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
UY26754A1 (es) Derivados de la 1, 3, 8, -triaza-spiro (4,5) decan-4-ona
RU2004132204A (ru) Имидазоконденсированные соединения
AR036044A1 (es) Compuestos piranoindazoles, composiciones farmaceuticas y su uso para la manufactura de un medicamento para el tratamiento del glaucoma
AR038864A1 (es) Inhibidores pirimidina y piridina biciclicos de la p38 quinasa
SE0302760D0 (sv) New compounds
AR058347A1 (es) Entidades quimias composiciones y metodos
WO2002089813A3 (en) 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
CY1106335T1 (el) Υποκατεστημενα παραγωγα 4-φαινυλ-4[1η-ιμιδαζολ-2-υλ]-πιπepιδινης για τη μειωση της ισχαιμικης βλαβης
NO20051282L (no) Antitumorale analoger av lamellariner.
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
MXPA04006033A (es) Dicetopiperacinas sustituidas como antagonistas de oxitocina.
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
RU2374228C2 (ru) Производные 4-фенилпиперидина в качестве ингибиторов ренина
RU2009128968A (ru) Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии
DE69824450D1 (de) Biphenylamidin-derivate
DK1390036T3 (da) Prostansyrederivater som midler til nedsættelse af intraokulært tryk
WO2005005394A3 (en) Thiophenylaminoimidazolines as prostaglandin i2 antagonists
ATE308540T1 (de) Antithrombosemittel
ES2452026T3 (es) Prostaglandinas y análogos como agentes para disminuir la presión intraocular

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees